IOBT 13D/13G Filings - IO Biotech Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2022-09-30 4:51 pm Unchanged	2022-09-27	13D	IO Biotech, Inc. IOBT	Novo Holdings A/S	3,277,932 11.400%	0 (Unchanged)	Filing History
2022-05-26 11:57 am Unchanged	2022-05-25	13D	IO Biotech, Inc. IOBT	Novo Holdings A/S	3,277,932 11.300%	0 (Unchanged)	Filing History
2022-04-25 4:48 pm Purchase	2022-04-13	13G	IO Biotech, Inc. IOBT	PFM Health Sciences, LP	1,510,136 5.200%	1,510,136 (New Position)	Filing History
2022-02-11 4:02 pm Purchase	2021-12-31	13G	IO Biotech, Inc. IOBT	HBM BIOVENTURES CAYMAN LTD	2,420,484 8.400%	2,420,484 (New Position)	Filing History
2022-02-11 10:05 am Purchase	2021-12-31	13G	IO Biotech, Inc. IOBT	AVORO CAPITAL ADVISORS LLC	2,055,883 7.100%	2,055,883 (New Position)	Filing History
2021-11-19 4:30 pm Purchase	2021-11-19	13G	IO Biotech, Inc. IOBT	RA Capital Management, L.P.	1,857,755 6.400%	1,857,755 (New Position)	Filing History
2021-11-19 4:15 pm Purchase	2021-11-09	13D	IO Biotech, Inc. IOBT	Lundbeckfond Invest A/S	6,049,452 21.800%	6,049,452 (New Position)	Filing History
2021-11-12 4:30 pm Purchase	2021-11-09	13G	IO Biotech, Inc. IOBT	Vivo Capital IX, LLC	3,015,545 10.500%	3,015,545 (New Position)	Filing History
2021-11-10 4:43 pm Purchase	2021-11-04	13D	IO Biotech, Inc. IOBT	Novo Holdings A/S	3,277,932 11.800%	3,277,932 (New Position)	Filing History

Goto Prev, 0, 1